These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16787419)

  • 1. Chaperone protein 14-3-3 and protein kinase A increase the relative abundance of low agonist sensitivity human alpha 4 beta 2 nicotinic acetylcholine receptors in Xenopus oocytes.
    Exley R; Moroni M; Sasdelli F; Houlihan LM; Lukas RJ; Sher E; Zwart R; Bermudez I
    J Neurochem; 2006 Aug; 98(3):876-85. PubMed ID: 16787419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
    Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
    Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors.
    Zwart R; Broad LM; Xi Q; Lee M; Moroni M; Bermudez I; Sher E
    Eur J Pharmacol; 2006 Jun; 539(1-2):10-7. PubMed ID: 16674940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
    Briggs CA; Gubbins EJ; Marks MJ; Putman CB; Thimmapaya R; Meyer MD; Surowy CS
    Mol Pharmacol; 2006 Jul; 70(1):227-40. PubMed ID: 16569710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes.
    Zwart R; Vijverberg HP
    Mol Pharmacol; 1998 Dec; 54(6):1124-31. PubMed ID: 9855643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
    Gotti C; Moretti M; Meinerz NM; Clementi F; Gaimarri A; Collins AC; Marks MJ
    Mol Pharmacol; 2008 Jun; 73(6):1796-807. PubMed ID: 18337473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination.
    Anderson DJ; Malysz J; Grønlien JH; El Kouhen R; Håkerud M; Wetterstrand C; Briggs CA; Gopalakrishnan M
    Biochem Pharmacol; 2009 Oct; 78(7):844-51. PubMed ID: 19555668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat nicotinic acetylcholine receptor alpha2beta2 channels: comparison of functional properties with alpha4beta2 channels in Xenopus oocytes.
    Khiroug SS; Khiroug L; Yakel JL
    Neuroscience; 2004; 124(4):817-22. PubMed ID: 15026122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
    Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
    Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
    Zwart R; Carbone AL; Moroni M; Bermudez I; Mogg AJ; Folly EA; Broad LM; Williams AC; Zhang D; Ding C; Heinz BA; Sher E
    Mol Pharmacol; 2008 Jun; 73(6):1838-43. PubMed ID: 18367540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression.
    Carbone AL; Moroni M; Groot-Kormelink PJ; Bermudez I
    Br J Pharmacol; 2009 Mar; 156(6):970-81. PubMed ID: 19366353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-induced conformational changes in the extracellular domain of alpha 7 nicotinic acetylcholine receptors.
    Lyford LK; Sproul AD; Eddins D; McLaughlin JT; Rosenberg RL
    Mol Pharmacol; 2003 Sep; 64(3):650-8. PubMed ID: 12920201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The additional ACh binding site at the α4(+)/α4(-) interface of the (α4β2)2α4 nicotinic ACh receptor contributes to desensitization.
    Benallegue N; Mazzaferro S; Alcaino C; Bermudez I
    Br J Pharmacol; 2013 Sep; 170(2):304-16. PubMed ID: 23742319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel G423S mutation of human alpha7 nicotinic receptor promotes agonist-induced desensitization by a protein kinase C-dependent mechanism.
    Tsuneki H; Kobayashi S; Takagi K; Kagawa S; Tsunoda M; Murata M; Matsuoka T; Wada T; Kurachi M; Kimura I; Sasaoka T
    Mol Pharmacol; 2007 Mar; 71(3):777-86. PubMed ID: 17132684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of nicotine- and acetylcholine-evoked currents through alpha4beta2 neuronal nicotinic receptors by tobacco cembranoids in Xenopus oocytes.
    Eaton MJ; Ospina CA; Rodríguez AD; Eterović VA
    Neurosci Lett; 2004 Aug; 366(1):97-102. PubMed ID: 15265598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry.
    Indurthi DC; Qudah T; Liao VW; Ahring PK; Lewis TM; Balle T; Chebib M; Absalom NL
    Pharmacol Res; 2019 Jan; 139():215-227. PubMed ID: 30472464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
    Mihalak KB; Carroll FI; Luetje CW
    Mol Pharmacol; 2006 Sep; 70(3):801-5. PubMed ID: 16766716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of valine 7' of TMD2 to gating of neuronal alpha3 receptor subtypes.
    Nieves-Cintrón M; Caballero-Rivera D; Navedo MF; Lasalde-Dominicci JA
    J Neurosci Res; 2006 Dec; 84(8):1778-88. PubMed ID: 17044037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering α4β2 nAChRs with reduced or increased nicotine sensitivity via selective disruption of consensus sites in the M3-M4 cytoplasmic loop of the α4 subunit.
    Biaggi-Labiosa NM; Avilés-Pagán E; Caballero-Rivera D; Báez-Pagán CA; Lasalde-Dominicci JA
    Neuropharmacology; 2015 Dec; 99():273-84. PubMed ID: 25957813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
    Smulders CJ; Zwart R; Bermudez I; van Kleef RG; Groot-Kormelink PJ; Vijverberg HP
    Eur J Pharmacol; 2005 Feb; 509(2-3):97-108. PubMed ID: 15733544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.